Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range o...
| Main Authors: | Yu-long Hu, Qiaoli Ma, Xiaoqiang Dong, Yuanfang Kong, Juntao Cai, Jieming Li, Chunhong Dong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2023.1107551/full |
Similar Items
-
Anti-inflammatory Effect of a Novel Pectin Polysaccharide From Rubus chingii Hu on Colitis Mice
by: Yuanfang Kong, et al.
Published: (2022-04-01) -
Quinazolinones as Potential Anticancer Agents: Synthesis and Action Mechanisms
by: Zhijiang Deng, et al.
Published: (2025-02-01) -
Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
by: Yajie Fu, et al.
Published: (2022-11-01) -
Treatment regimens for non-alcoholic fatty liver disease
by: Brian P. Lam, et al.
Published: (2009-01-01) -
Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
by: Aybike Birerdinc, et al.
Published: (2018-01-01)